RAC
RACURA FPO [RAC]
Healthcare · ASX Small Cap
$2.1000 -1.4%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when RAC triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Strong cash runway (17 quarters)
- Very high P/S ratio (145.1x)
- EPS estimates revised downward (-10pts)
- Near 52-week low (17% of range)
- Sentiment is mixed — no strong consensus either way
- Altman Z-Score grey zone (1.84, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- MACD crossed bearish — momentum is fading
- Below the 200-day average — the long-term trend is still working against it
- Revenue declining (-12%)
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 42% over the past year
- Revenue declining at -12% — the top line is shrinking
Expected next for RAC
Window: 3 Nov to 17 Nov
The last 3 moved RAC -2.2% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
LOW RC220 MYC-silencing data to be presented FCS 26 conference
NONE Racura Oncology Adelaide Investor Briefing
NONE Notification regarding unquoted securities - RAC
NONE CPACS Trial Opens for RC220 Patient Enrolment in Korea
Recent ASX Announcements
| 2026-09-07 | RC220 MYC-silencing data to be presented FCS 26 conference |
| 2026-09-03 | Racura Oncology Adelaide Investor Briefing |
| 2026-09-01 | Notification regarding unquoted securities - RAC |
| 2026-08-31 | CPACS Trial Opens for RC220 Patient Enrolment in Korea PRICE SENSITIVE |
| 2026-08-25 | Corporate Governance Statement |
Key Metrics
$407.8M
Market Cap
75K
Avg Volume
1.4x
Vol Ratio
$1.49 — $4.90
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
-42.3%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 70% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | weak | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track RAC and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required